|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5995 USD | -6.63% |
|
-14.95% | -55.59% |
By Josh Beckerman
Biora Therapeutics Inc. shares rose 26% to $6.83 on volume of more than 54.4 million shares, compared with a 65-day average of 940.298.
On Monday, after Biora discussed feedback from the Food and Drug Administration about its PGN-600 program, shares rose 2% to $2.11. The next day the stock skyrocketed to close at $5.40 after HC Wainwright raised its price target to $65 from $6.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
01-11-23 1614ET
| 1st Jan change | Capi. | |
|---|---|---|
| -55.59% | 23.04M | |
| -3.30% | 102B | |
| +1.79% | 96.84B | |
| -0.44% | 21.48B | |
| -18.35% | 20.82B | |
| -7.45% | 18.6B | |
| -40.31% | 16.81B | |
| -26.84% | 13.78B | |
| +0.59% | 13.4B | |
| +20.86% | 11.06B |
BIORA THERAPEUTICS, INC. 
